The Cost-Effectiveness of Emergency Hormonal Contraception with Ulipristal Acetate versus Levonorgestrel for Minors in France | PLOS ONE
![WO2021084345A1 - Pharmaceutical composition comprising mitotane administered orally for treatment of adrenocortical carcinoma and cushing's syndrome - Google Patents WO2021084345A1 - Pharmaceutical composition comprising mitotane administered orally for treatment of adrenocortical carcinoma and cushing's syndrome - Google Patents](https://patentimages.storage.googleapis.com/45/cd/60/8a12fb1f033943/imgf000015_0001.png)
WO2021084345A1 - Pharmaceutical composition comprising mitotane administered orally for treatment of adrenocortical carcinoma and cushing's syndrome - Google Patents
![PDF) Cost-effectiveness analysis of emergency hormonal contraception with ulipristal acetate versus levonorgestrel PDF) Cost-effectiveness analysis of emergency hormonal contraception with ulipristal acetate versus levonorgestrel](https://www.researchgate.net/publication/288103286/figure/tbl3/AS:667788142194688@1536224508134/Incremental-cost-and-effectiveness-of-ulipristal-acetate-versus-levonorgestrel-UPA_Q320.jpg)